Description
Trifluorothymidine, ≥99% by HPLC, 100MG
Synonym(s):
α,α,α-Trifluorothymidine, 2′-Deoxy-5-trifluoromethyluridine, Trifluorothymine deoxyriboside, Trifluridine
Empirical Formula (Hill Notation):
C10H11F3N2O5
CAS Number:
70-00-8
Molecular Weight:
296.20
EC Number:
200-722-8
MDL number:
MFCD00006534
PubChem Substance ID:
24900027
NACRES:
NA.51
PROPERTIES
biological source
synthetic
Quality Level
100
assay
≥99% (HPLC)
form
powder
mp
190-193 °C (lit.)
solubility
water: 50 mg/mL, clear, colorless
storage temp.
−20°C
SMILES string
OC[C@H]1O[C@H](C[C@@H]1O)N2C=C(C(=O)NC2=O)C(F)(F)F
InChI
1S/C10H11F3N2O5/c11-10(12,13)4-2-15(9(19)14-8(4)18)7-1-5(17)6(3-16)20-7/h2,5-7,16-17H,1,3H2,(H,14,18,19)/t5-,6+,7+/m0/s1
InChI key
VSQQQLOSPVPRAZ-RRKCRQDMSA-N
DESCRIPTION
Application
Trifluorothymidine has been used as a component of selection medium to screen thymidine kinase (TK) mutants in lymphoma cells,[1] human lymphoblastoid TK6 cells,[2] and L5178Y mouse lymphoma cells.[3]
Biochem/physiol Actions
Trifluorothymidine is a thymidine analog[4] and is light sensitive.[1] TFT serves as a thymidine kinase substrate to study enzyme specificity and kinetics.[5] Incorporation of phosphorylated TFT into DNA induces damage,[6] making it useful for DNA repair studies. TFT may also be used in the inhibition of thymidylate synthase[5] and in screening mutant thymidine kinase gene.[1]. It elicits antitumor activity in gastrointestinal (GI) cancers[7] and has therapeutic potential to treat herpetic keratitis.[4]
Packaging
Bottomless glass bottle. Contents are inside inserted fused cone.
SAFETY INFORMATION
Signal Word
Warning
Hazard Statements
H341 - H351 - H361d
Precautionary Statements
P201 - P202 - P280 - P308 + P313 - P405 - P501
Hazard Classifications
Carc. 2 - Muta. 2 - Repr. 2
Storage Class Code
11 - Combustible Solids
WGK
WGK 3
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable
Personal Protective Equipment
dust mask type N95 (US), Eyeshields, Gloves